Latest filing published 25 Sept 2026 for Strata Critical Medical, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
William A. Heyburn (chief executive) discloses dealings in Strata Critical Medical, Inc. to SEC (Form 4). In total, 50 filings cover trades dated from 13 August 2021 to 24 September 2026.
In open-market terms, that means 1 purchase worth €65k on one side and 15 sales worth €1.6M on the other. On balance, insiders were net sellers of €1.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 23 share grants and 11 option exercises.
On 25 September 2026 came the latest disclosure, a share grant for €455k in Strata Critical Medical, Inc. The most recent open-market purchase was published on 10 December 2025, 312 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 50 declarations